Resource Library
Showing 11 to 20 of 327 results
Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults and can vary from person to person. This is why a one-size-fits-all treatment approach is not optimal. Research advances in how we treat CLL are discussed by Dr. Anthea Peters, Hematologist at the Cross Cancer Institute in Edmonton, and Associate Professor, Department of…
Short animated video about the active surveillance approach (watch and wait) to help you understand the benefits and find out what it means for you.
Short animated video describing the chronic Lymphocytic Leukemia (CLL)
Amy Pulsifer talks about her experience managing long term effects due to her Chronic Lymphocytic Leukemia (CLL).
Dr. Philip Kuruvilla talks to us about current chronic lymphocytic leukemia (CLL) treatment options, potential side effects and how to manage them.
Learn about the watch and wait approach, understand the benefits and find out what it means for you.
Learn about CLL, how it is diagnosed, an overview of treatments and what happens next.
Gary Su, of Calgary, was diagnosed with acute myeloid leukemia (AML) in his 30s and underwent a stem cell transplant with his sister as donor. He says the Leukemia and Lymphoma Society of Canada became his guiding light, offering a wealth of reliable information and connecting him with a supportive community.
Acute myeloid leukemia (AML) is a type of cancer that forms in blood cells and bone marrow that progresses rapidly if untreated. In this presentation, Dr. Brett Houston, a hematologist at the University of Manitoba, will speak about her work in clinical trials in finding ways to optimize care and improve outcomes for patients affected with acute leukemia,…